Table 2.
Effect of WDL-AuNPs on glucose, insulin, and liver glycogen in normal and diabetic rats.
| Group | Glucose (mg/dL) |
Insulin (µU/mL) |
Glycogen (mg/100g Tissues) |
|---|---|---|---|
| Control | 102.01 ± 9.25 ad | 11.61 ± 1.09 a | 51.94 ± 4.30 a |
| WDL-AuNPs (40 mg/kg bw) | 94.81 ± 8.41 a | 10.98 ± 0.91 a | 53.01 ± 3.51 a |
| DEHP | 190.44 ± 15.65 b | 5.16 ± 0.85 b | 24.34 ± 2.01 b |
| DEHP + WDL-AuNPs (10 mg/kg bw) |
170.63 ± 13.54 c | 6.44 ± 0.45 c | 35.11 ± 2.89 c |
| DEHP + WDL-AuNPs (20 mg/kg bw) |
165.84 ± 12.54 c | 7.09 ± 0.78 cd | 39.18 ± 3.14 d |
| DEHP + WDL-AuNPs (40 mg/kg bw) |
120.91 ± 11.69 d | 8.11 ± 0.69 d | 43.79 ± 4.29 d |
Values are given as means ± S.D. for six rats in each group. Values not sharing a common superscript differ significantly (a–d) at p ≤ 0.05 Duncan’s Multiple Range Test (DMRT).